Therapy Areas
24 March 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) said on Tuesday that they have received marketing and manufacturing authorisation in Japa...
24 March 2026 - Global healthcare company Abbott (NYSE:ABT) confirmed on Monday that it has completed the acquisition of molecular diagnostics company Exact Sciences.According to Abbott, this acquisition establishes its position as a leader in fast-g...
24 March 2026 - PANTHERx Rare Pharmacy, a specialty pharmacy focused on rare and orphan diseases, announced on Monday that it has been selected by Belgium-based biopharmaceutical company UCB (EBR:UCB) as the exclusive specialty pharmacy for the distr...
24 March 2026 - Swiss healthcare company Roche (SIX: RO, ROP) (OTCQX: RHHBY) announced on Tuesday that it has introduced the cobas eplex respiratory pathogen panel 3 (RP3), a new diagnostic test designed to detect a broad spectrum of viruses and bact...
23 March 2026 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Photonova Spectra, its next-generation photon-counting CT system. The ...
23 March 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) announced on Monday that it has initiated a registrational Phase III clinical trial of HMPL-760 in combination with R-GemOx in patients with relaps...
23 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Monday reported positive topline results from the Phase 3 VALOR trial of their Lyme disease vaccine candida...